Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dr. Christopher Biggs specializes in radiation oncology and is an expert in radiosurgery and gynecological oncology.
Dr. Biggs co-founded Arizona Center for Cancer Care in 2008 with Drs. Devinder Singh, Daniel Reed and Terry Lee. He attended the University of Arizona, where he received his Bachelor of Science degree in Molecular and Cellular biology. His interest in cancer research took him to the University of Southern California, under the Borchard Cancer Research Fellowship. There, he performed research on the molecular genetics of cancer at the Norris Cancer Center and at LA Children’s Hospital. After completing his Doctor of Philosophy degree, he moved to Stanford University, where he earned his medical degree, and developed an interest in radiation oncology. Dr. Biggs completed his residency in radiation oncology at the University of California, San Francisco, where he eventually served as chief resident.
For five years, Dr. Biggs performed radiosurgery at Barrow Neurological Institute and also served as director of the Baptist Oncology Center.
Dr. Biggs is certified by the American Board of Radiology and is a Diplomat of the American Society of Therapeutic Radiation Oncology. He is a member of the American Association for Cancer Research, Radiology Society of North America, American Society of Therapeutic Radiation Oncology and the American Association of Advancement of Science.
Dr. Biggs is a multi-year “Top Doc” honoree by Phoenix Magazine.
"My experience was great I even had to travel from Yuma AZ for my treatments. DR Biggs made everything go as easy and painless for me. his staff were extremely kind and professional just like him! I appreciate so much for their empathy they had for me and my battle with cancer. Thank you from the bottom of my heart. I highly recommend this office." -Jen
"The office visit was for my husband Jessie Wilson. Dr. Biggs is excellent at relieving any anxiety we had going in. He took the time to explain everything as well as talking about personal info to get to know us better. We left feeling very relaxed and confident in his care moving forward. We highly recommend Dr. Biggs and his entire staff to anyone who needs treatment!" -Linda
Dr. Terry Lee specializes in radiation oncology, and has extensive experience in brain, head and neck, lung, and gastrointestinal cancer.
Dr. Lee co-founded Arizona Center for Cancer Care in 2008 with Drs. Devinder Singh, Christopher Biggs and Daniel Reed. He received his Bachelor of Science degree in Mechanical Engineering from the University of California, Los Angeles, and his Master of Science degree in Nuclear Engineering from the Massachusetts Institute of Technology, where he explored new treatment options for brain tumors using Boron Neutron Capture Therapy. Dr. Lee attended medical school at Tufts University School of Medicine, where he would also complete his internship, before completing his residency at the University of California, San Francisco, where he would eventually serve as chief resident.
Dr. Lee certified by the American Board of Radiology, and he is a Diplomat of the American Society of Therapeutic Radiation Oncology. He is a multi-year “Top Doc” honoree by Phoenix Magazine.
"Dr. Lee and all personnel are very good the Dr. explained with details my problem and all personnel are professional and treated me with care." -Sylvia
"Dr. Lee was great, kept us updated with treatment. Checking how everything thing was going & answered all questions. The staff was always very will to help! Thanks again!!!!!!!!!!" -Tom
Rezwan Chowdhury, MD is dual board certified by the American Board of Radiology, and The Royal College of Physicians and Surgeons (Canada), in Radiation Oncology. He completed his residency and Medical Doctorate at the Cross Cancer Institute in Edmonton, Alberta, Canada. He has a special interest in breast cancer, lung cancer, SBRT, brachytherapy, PLUVICTO, LUTATHERA, and treats all tumor sites.
Dr. Chowdhury is fellowship trained in brachytherapy, including all modalities of breast brachytherapy. He has specialized training and is experienced in treating lung cancer, brain metastases and oligo-metastases using SBRT/SRS techniques. Dr. Chowdhury has over 5 years of clinical academic experience at the University of British Columbia/BC Cancer Agency, where he was a clinical instructor to medical students, residents and fellows and served as the Chair of the SBRT program, thoracic tumor site and breast brachytherapy program. Dr Chowdhury has extensive research experience and has published his findings and presented to other specialty physicians around the world.
Dr. Chowdhury joined Arizona Center for Cancer Care in 2021 and has been treating patients throughout the Phoenix metro area for nearly a decade. Dr. Chowdhury believes in using evidenced based medicine, and a compassionate approach that places an emphasis on his patient’s individual needs and desires.
"Very knowledgeable and very good with patients, taking time to fully inform about options." -Ed
"Dr. Chowdhury explains all procedures and treatments thoroughly and takes time to answer any questions the patient may have prior and during treatment." -Ralph
Janice is a dedicated hematology/oncology nurse practitioner who collaborates closely with physicians and other healthcare team members to deliver comprehensive care, offering unwavering support to patients and caregivers during treatment and beyond. With over 12 years of experience as a hematology, oncology, and bone marrow transplant nurse, Janice has worked with medically complex neonates, pediatrics, and adults in both inpatient and outpatient settings. She earned both a bachelor's and a master's degree from the University of Phoenix and is nationally certified as a Nurse Practitioner by the American Association of Nurse Practitioners. Passionate about patient advocacy and education, Janice seeks to empower patients by listening to their health needs and goals and working in partnership with them and their families to manage their health effectively.
Dr. Justin Goldfarb specializes in medical oncology, internal medicine, and hematology.
Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.
Dr. Goldfarb earned a bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.
"The care I receive from Dr. Goldfarb is exceptional. He listens attentively to my concerns and he provided me with a treatment plan that yields positive results. The entire team at the clinic display a high level of professionalism and make me feel comfortable while I'm there . Nicole Lee is exceptional as well." -Christian
"Dr Goldfarb has been helping me fight lung cancer for two years and is a very caring person." -JC
Robin is a certified nurse practitioner at the Arizona Center for Cancer Care, working alongside Dr. Parmjeet Banghar. She obtained her Bachelor of Science in Nursing at Ameritech College of Nursing in Draper, Utah, and completed her Master of Nursing at Grand Canyon University, as an Acute Care Nurse Practitioner, with an emphasis on Adult Gerontology.
Prior to becoming a nurse practitioner, Robin worked as a registered nurse for Virginia G. Piper Cancer Care. Having extensive experience working in oncology/hematology, she understands the importance of providing a patient-centered approach. Robin is passionate about providing individualized treatment plans and promoting patient advocacy.
In her spare time, Robin enjoys spending time with her family. Shehas three adult children, two boys, Gabriel and Rowan, and one daughter Baylee. She also has an Aussiedoodle, named Bajie. She loves to travel, explore the outdoors, and on occasion play a round of golf.
Dr. Albert Amini is the founder and President of Arizona Premier Surgery as well as a board-certified General Surgeon with fellowship training in minimally invasive surgery for the liver, pancreas, and bile ducts. After earning his medical degree from Northwestern and completing his surgical internship and residency, Dr. Amini spent an additional year learning about hepatobiliary and pancreatic surgery, along with how to use modern technology to perform effective, minimally invasive surgery. Dr. Amini is board certified by the American College of Surgeons and he is also a member of the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition to a full schedule of patients at Arizona Premier Surgery, Dr. Amini travels abroad to perform surgeries on underserved patients in the Dominican Republic, which has improved his fluency in Spanish.
Dr. Amini has a special interest in pancreas surgery, gastrointestinal (GI) oncology and complex hernia repairs. At Arizona Premier Surgery, some of the surgeries he performs are hepatobiliary and pancreatic surgery, as well as gastrointestinal oncology, and colorectal surgery. Dr. Amini has expertise in the da Vinci® robotic surgical system and advanced laparoscopic surgery. Using laparoscopic and robotic techniques, Dr. Amini is able to perform minimally invasive surgery that needs less recovery time than traditional open surgery. In most cases, the pain and discomfort after surgery is much less for patients after laparoscopic/robotic surgery. Although he has already spent many years studying and practicing surgery, Dr. Amini continues to look for techniques and technology that can improve treatment for his patients at Arizona Premier Surgery.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Arizona Center for Cancer Care is a cancer center without walls, offering the best doctors, best treatments, best technologies, and best research to give patients the best care possible. With offices in Avondale, Chandler, Gilbert, Glendale, Mesa, Phoenix, Scottsdale, Surprise, Anthem, Peoria, Fountain Hills, Wickenburg, Apache Junction, Sun City, Sun City West, Goodyear, Prescott Valley, and Tempe, Arizona, the multi-specialty practice cares for more than 30,000 patients across the Valley.
The practice uses the most current treatment options available, including various forms of radiation oncology and medical oncology, and hematology. The center also includes experts in gynecologic oncology and breast surgery and has a newly diagnosed breast cancer clinic.
The board-certified radiation oncologists at Arizona Center for Cancer Care use positron emission tomography/computed tomography (PET/CT) imaging to reveal the presence and severity of cancer and create an effective treatment plan.
Dedicated to providing its patients with the most current drugs and therapies available, Arizona Center for Cancer Care participates in multiple clinical trials.
Cancer is a disease of survivors, and Arizona Center for Cancer Care is keeping it that way.
For comprehensive, high-quality cancer care, call Arizona Center for Cancer Care or schedule an appointment online today. Telemedicine appointments are available.
Dr. Giraldo Kato specializes in medical oncology and hematology and has a special interest in breast cancer. His research interests include new breast cancer therapies as well as gastrointestinal and thoracic malignancies.
Dr. Kato joined Arizona Center for Cancer Care in 2013, when his team at Pinnacle Oncology Hematology partnered with the practice. Prior to joining Pinnacle Oncology, Dr. Kato served as chief of hematology/oncology at Maricopa Medical Center. He is a member of American Society of Clinical Oncology, American Medical Association and The American Society of Hematology. He is certified by the Medical Oncology Board and American Board of Internal Medicine.
"Dr Kato’s oncology expertise is a gift to his patients!! Diagnosed with triple negative breast cancer in 2016, I saw Dr Kato after meeting with several medical oncologists. I remember that appointment to this day. Not only did Dr Kato share his clinical plan with me, he shared a copy of a recently published peer reviewed clinical study that supported his treatment plan for me. Evidence based medicine. I was fortunate to see 4 medical oncologist in a span of a week sometimes multiple times, even after hours to ensure our questions were addressed for which I am immensely thankful. In the end, prayer and faith led me to chose Dr Kato. As a triple negative breast cancer survivor, my treatments were necessarily aggressive and difficult. 5 months of Chemo therapy followed by surgery then full dose of radiation. Through it all, I had Dr Kato and his team by my side. Chemo nurses were incredible and deserve a lot of praise for the work they do..." -Mei
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Joan Dahmer specializes in hematology, medical oncology, and internal medicine.
Dr. Dahmer joined Arizona Center for Cancer Care in 2008 when her team at Arizona Center for Hematology and Oncology partnered with the practice. Prior to joining Arizona Center for Hematology and Oncology in 2002, Dr. Dahmer developed the oncology program at both Maryvale and Memorial Hospitals in Phoenix. She was also Chief of Medicine at Laurentian Hospital in California and has served as a medical consultant for prominent centers and labs.
Dr. Dahmer has been active in the medical community as a past or current member of several organizations, most recently as a member of The Arizona Clinical Oncology Society, the American Society of Hematology, and the Association of Community Cancer Centers, to name a few.
She has also volunteered her time to many health-related causes, including serving as medical director for the HAVEN Program of Northeastern Ohio, a comprehensive program for those infected with and affected by HIV.
She has presented on a number of topics including, medical marijuana, cardiac assessment in home care to home health nurses, women in medicine, oral & lung cancer and medicine as a career.
"Dr. Dahmer is very good, kind, understanding, and very professional 👏." -Cozetta
"Virginia Piper cancer center has the nicest. Most accommodating staff and nurses. Doc Dahmer is the best doctor I have heard of. She is patient. Kind. Incredibly smart. Very thorough. I just love her. You wont be disappointed with her." -Samantha
After graduating from a premier medical school in India, Dr. Fernandes continued her training in Internal Medicine and obtained advanced training in the treatment of blood and cancer disorders in the United States. She was awarded an international prestigious scholarship from the European Society of Medical Oncology and spent time as a visiting fellow in Medical Oncology in Spain.
Her areas of expertise include breast cancers in addition to treating other cancer disorders such as colon cancer, lung cancer, melanoma/skin cancers and blood disorders such as anemias, iron deficiency disorders, abnormal blood counts. She serves as a section editor for Breast Cancer on hemonc.org, an internationally accessed online resource for cancer physicians. She has presented cancer research at national and international cancer meetings in the United States and Europe and volunteers with the American Society of Clinical Oncology for peer review activities.
Dr. Fernandes believes in providing compassionate, exceptional and cutting-edge care to her patients. She strives to provide the most personalized treatment plan for her patients while taking into consideration their unique needs. Having had family members who have also been stricken with cancer, she understands and empathizes with the needs of caring for a loved one with cancer.
Dr. Fernandes enjoys spending time with family, travel, running, and watercolor painting.
